# Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)

> **NCT00774423** · PHASE2,PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 141 (actual)

## Conditions studied

- SMA

## Interventions

- **DRUG:** Riluzole

## Key facts

- **NCT ID:** NCT00774423
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2013-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774423, "Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00774423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*